list all the biologics indicadet for ulcerative colitis and the success rate in the…
- User
list all the biologics indicadet for ulcerative colitis and the success rate in the following format: vendor, biologic name, success rate
- Assistant
Vendor: AbbVie Biologic Name: Humira (adalimumab) Success Rate: Approximately 30-40% of patients achieve clinical remission after treatment with Humira.
Vendor: Janssen Biotech Biologic Name: Remicade (infliximab) Success Rate: Around 50% of patients experience clinical response and remission with Remicade.
Vendor: Takeda Pharmaceuticals Biologic Name: Entyvio (vedolizumab) Success Rate: Clinical remission rates with Entyvio range from 30% to 40% in patients with ulcerative colitis.
Vendor: Pfizer Biologic Name: Xeljanz (tofacitinib) Success Rate: Studies have shown that approximately 25-30% of patients achieve remission with Xeljanz.
Vendor: Celltrion Healthcare Biologic Name: Remsima (infliximab biosimilar) Success Rate: Similar to Remicade, Remsima has a success rate of around 50% in inducing and maintaining remission.
Please note that success rates may vary depending on individual patient factors and the stage/severity of ulcerative colitis. It is always recommended to consult with a healthcare professional for personalized treatment options and success rates.
- User
list all the biologics indicadet for ulcerative colitis and the success rate in the following format: vendor, biologic name, commercial name, success rate in a strict conscie format
- Assistant
Vendor: AbbVie Biologic Name: Adalimumab Commercial Name: Humira Success Rate: 30-40%
Vendor: Janssen Biotech Biologic Name: Infliximab Commercial Name: Remicade Success Rate: 50%
Vendor: Takeda Pharmaceuticals Biologic Name: Vedolizumab Commercial Name: Entyvio Success Rate: 30-40%
Vendor: Pfizer Biologic Name: Tofacitinib Commercial Name: Xeljanz Success Rate: 25-30%
Vendor: Celltrion Healthcare Biologic Name: Infliximab biosimilar Commercial Name: Remsima Success Rate: 50%
Other models, same or similar prompt
Responses were produced in different, uncontrolled contexts (system prompts, settings, prior turns). This is not a benchmark.